CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


collection of swabsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug3272 fingertip tests for POC assays Wiki 1.00
drug3454 saliva collection Wiki 1.00
drug3205 blood draw Wiki 0.71

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007239 Infection NIH 0.05

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses (SERO-BL-COVID-19)

The study is to investigate the antibody response in the blood and saliva of people with a known COVID-19 infection in the canton of Baselland.

NCT04483908 COVID-19 Infection Diagnostic Test: blood draw Diagnostic Test: fingertip tests for POC assays Diagnostic Test: saliva collection Diagnostic Test: collection of swabs
MeSH:Infection

Primary Outcomes

Description: Qualitative method validation: qualitative result of the ELISA (Patient does / does not have immunity) as the gold standard compared to the POC using univariate measures to derive sensitivity and specificity of the POC.

Measure: Qualitative method validation (yes/ no)

Time: at baseline

Description: Quantitative method validation: antibody concentration from the ELISA are related to the dichotomous result from POC.

Measure: Quantitative method validation (antibody concentrations)

Time: at baseline

Secondary Outcomes

Description: Antibody and T cell repertoires and transcriptional profiles of cells will be used to identify potential antibody and T cell clones correlated with COVID-19 protection.

Measure: Immune cell repertoire sequencing

Time: at baseline


No related HPO nodes (Using clinical trials)